Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dinutuximab Beta LTI +/- IL-2 in Neuroblastoma
NCT01701479Phase 2Unknown
- Sponsor
- St. Anna Children's Cancer Research Institute
- Start
- Jan 2012
- Primary completion
- Dec 2020
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of Dinutuximab beta in neuroblastoma, sponsored by St. Anna Children's Cancer Research Institute. Status: unknown.
02
Drugs
Dinutuximab beta
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT01701479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01701479.